Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared with 2018, while...
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed to meet its...
A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to persuade physicians to prescribe...
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders,...
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the recommendation of Astellas’ Xospata (...
AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug watchdog NICE in the...
The European Commission has awarded conditional marketing approval to Roche’s Polivy for the treatment of relapsed or refractory diffuse large B-...
Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve...
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared with 2018.
Following the recommendation of the tablet formulation of the drug for use on the NHS in England and Wales, news has broken that AstraZeneca and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches